Cathie Wood’s ARK Invest ETFs (exchange-traded funds) published its daily trades for Monday, November 3, 2025. The standout move was a large purchase of 238,346 shares of Bullish (BLSH) across its ARK Innovation ETF (ARKK), ARK Next Generation Internet ETF (ARKW), and ARK Fintech Innovation ETF (ARKF), worth about $12.05 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
This marks ARK’s second Bullish purchase in less than a week, following another buy on October 31, when the firm acquired 105,013 shares worth about $5.25 million. The repeated move shows growing confidence in Bullish’s role in the digital asset space.
ARK Buys Beam Therapeutics
ARK also increased its stake in Beam Therapeutics (BEAM), buying 336,257 shares through its ARKK and ARK Genomic Revolution ETF (ARKG), valued at $8.4 million.
Beam focuses on gene-editing therapies, and the latest purchase adds to ARK’s steady buying in the biotech sector this year.
Wood Sells Stakes in Palantir, Roku, and Guardant Health
On the sell side, ARK trimmed several well-known holdings. It sold 38,338 shares of Palantir (PLTR) from the ARKK ETF for about $7.69 million. This follows recent profit-taking in Palantir after its strong share performance last week, with the stock up about 10% over the past five days.
Notably, Palantir reported strong Q3 results on Monday, posting earnings per share of $0.21, topping estimates of $0.17, and revenue of $1.18 billion, exceeding forecasts of $1.09 billion. Sales grew 63% year-over-year, driven by a 121% rise in U.S. commercial revenue and a 52% gain in government business. The company also raised its full-year outlook above Wall Street expectations.
ARK also sold 21,793 shares of Roku (ROKU) for $2.31 million, 13,426 shares of Guardant Health (GH) for $1.25 million, and 46,710 shares of Adaptive Biotechnologies (ADPT) for $810,885.
Let’s see how these stocks perform using the TipRanks Stock Comparison Tool:
